Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 18Gastrointestinal 3Breast 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Thoracic 1Head & Neck 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Adrenocortical Carcinoma 6Thyroid Carcinoma, Anaplastic 4Neoplasm Metastasis 4Sarcoma 3Pheochromocytoma 3Thyroid Neoplasms 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Ovarian Neoplasms 2Neurofibrosarcoma 2Neuroendocrine Tumors 2Neoplasms 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Fibrosarcoma 2Endometrial Neoplasms 2Thyroid Cancer, Papillary 1Somatostatinoma 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Mesothelioma, Malignant 1

Interventions

atezolizumab 2Trastuzumab 2Magnetic Resonance Spectroscopy 2vandetanib 1tivozanib 1tipifarnib 1temsirolimus 1romidepsin 1pembrolizumab 1pasireotide 1methyl hydroxyethyl cellulose 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1entinostat 1Walking 1Vinorelbine 1Suramin 1Standard of Care 1Specimen Handling 1Sirolimus 1Ritonavir 1Respiratory Therapy 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Doxorubicin × Endocrine × Clear all
NCT00003038 2011-08-03

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡